(no title)
anna-gabriella | 1 year ago
As for "nobody can re-produce", no, that's not the definition. Imaginary things are not competitive advantage. They are exaggerating, and that's bad. But yeah, that's what companies do, you are right.
anna-gabriella | 1 year ago
As for "nobody can re-produce", no, that's not the definition. Imaginary things are not competitive advantage. They are exaggerating, and that's bad. But yeah, that's what companies do, you are right.
FrustratedMonky|1 year ago
I get the impression you just aren't keeping up with DeepMind.
They have made huge break throughs in science, and they publish their results in Nature. Just because the parent company Google had some bad demo's doesn't mean it is all bunk.
So guess if you are of the ilk that just doesn't trust anything anymore, that there is no peer reviews, all science is a fraud. I really can't help that.
anna-gabriella|1 year ago
The team that did RL for chips work was at GoogleBrain, and you already pointed out that Google had bad demos. The fact that this team was absorbed into DeepMind does not magically rub the successes of DeepMind onto them.
The RL for chips results were nothing like AlphaGo. Imagine if AlphaGo claimed to beat unknown go players, you would laugh. But the Nature paper on RL for chips claims to outperform unknown chip engineers. Also, imagine if AlphaFold claimed to fold only proprietary proteins. The Nature paper on RL for chips reports results on a small set of proprietary chip blocks (they released one design, and the results are not great on that one). That's where imaginary results come up. One of these things is not like the others.
unknown|1 year ago
[deleted]